However, some studies have suggested that TRPC6 (over)expression could also protect podocytes against complement-mediated glomerular disease and that TRPC6 knock-out was not protective in a specific model of diabetic nephropathy [42,43]. This evidence concerns the gene TRPC6 and diabetic kidney disease.